The telehealth Software market is projected to expand its roots at a strong CAGR of 15.7% during the forecast period. The market is likely to hold a revenue of US$ 6.85 billion in 2023 while it is anticipated to cross a value of US$ 29.56 billion by 2033.
The growing adoption of various telehealth software such as real-time communication software, store and forward telehealth software, and remote patient monitoring telehealth software is driving the demand for the telehealth software market.
The growing adoption of mobile wireless technologies and mHealth solutions for public health is spurring global demand. Integration of advanced technologies such as Artificial Intelligence (AI) and Machine Learning, the Internet of Medical Things (IoMT), smart health devices, and Big Data in telehealth software boosts the market growth.
| Attributes | Details |
|---|---|
| Telehealth Software Market CAGR (2023 to 2033) | 15.7% |
| Telehealth Software Market Size (2023) | US$ 6.85 billion |
| Telehealth Software Market Size (2033) | US$ 29.56 billion |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The telehealth software market demand is estimated to rise at 15.7% CAGR between 2023 and 2033 in comparison with the 13.8% CAGR registered from 2018 to 2022. The global telehealth software market is anticipated to witness an increase in revenue from US$ 6.85 billion in 2022 to US$ 29.56 billion by 2030.
Future Market Insights identifies North America, followed by Europe, as the leading market. Expansion in North America is supported by the region’s developed infrastructure and the large presence of telehealth software providers in the United States. Telehealth software is a simple platform that is used by providers to connect with patients remotely and shares video and images and consult for healthcare services.
Telehealth software integrates with scheduling systems and providers’ electronic health records (EHR). It gives physicians a secure and organized system for:
Growing adoption of advanced technology such as AI and Big data analytics in telehealth software is driving the global demand. Big data helps to process data which is collected from telehealth modalities such as subjective data (symptoms and patient behavior) and objective (vital signs and ambient environment) along with historical data. It enables risk management and prediction. AI and machine learning creates significant potential in the telehealth software market. Telehealth and telemedicine improve:
Due to such advantages, the demand for the telehealth software market has increased over the years.
Principal Consultant
| Countries | Revenue Share % (2022) |
|---|---|
| The United States | 21.3% |
| Germany | 8.7% |
| Japan | 5.4% |
| Australia | 4.1% |
| North America | 37.2% |
| Europe | 24.3% |
| Countries | CAGR % (2023 to 2033) |
|---|---|
| China | 16.2% |
| India | 17.2% |
| The United Kingdom | 15.2% |
The market in the United States is anticipated to be valued at around US$ 3.85 billion by 2030. The country might expand at a CAGR of 12.9% from 2023 to 2033. The market holds a market share of 21.3% in 2023 while North America held the leading share of 37.2% in 2022.
The United States is one of the prominent countries in telehealth software solutions sales. As per the United States CDC, chronic diseases such as cancer, heart disease, and diabetes are the leading causes of disability and death in the United States. It leads to US$ 3.8 trillion in annual healthcare costs. Thus, the increasing prevalence of chronic conditions, increase in healthcare expenditure of the country, and increasing geriatric population spur the demand for the telehealth software market.
The market for telehealth software in Germany held a value of around US$ 1.01 billion in 2022. Germany’s telehealth software market held a market share of 8.7% in 2022 while Europe itself held a share of 24.3% in the same year.
Germany witnessed developed infrastructure for the healthcare industry due to the increasing penetration of smart technologies such as AI, ML, and AR/VR across the healthcare sector. According to the international trade administration, Germany’s medical device market is expected to show significant growth worldwide accounting for roughly US$ 35.8 billion annually, and 25.6% of the total Europe market. Thus, such development in Germany’s healthcare sector is ultimately propelling the demand for the telehealth software market.
As per FMI, overall telehealth software spending in India is likely to increase at a rate of almost 17.2% from 2023 to 2033. It held a market value of around US$ 780.2 million in 2022.
As per IBEF, India’s healthcare market increased three-fold to US$ 133.44 billion in 2022 and public expenditure by the government on the healthcare sector stood at 1.2% of the total GDP. Therefore, such development and government initiatives toward the healthcare sector are expected to drive the demand for the telehealth software market in India.
| Category | By Component Type |
|---|---|
| Leading Segment | Software |
| Market Share (2022) | 58.7% |
| Category | By Deployment Type |
|---|---|
| Leading Segment | On-Premises |
| Market Share (2022) | 57.6% |
By component, the software segment is expected to expand 2.2X by 2033 and is expected to register a leading CAGR of 16.2% from 2023 to 2033. The segment held a notable market share of 58.7% in 2022. Telehealth software is used for:
The rising adoption of telehealth software by many healthcare providers is augmenting the demand for the telehealth software market.
As per FMI, by deployment, the on-premise segment showcased a leading market share of around 57.6% in 2022. Moreover, the cloud-based segment is set to expand at a high CAGR of 17.1% from 2023 to 2033.
On-premise telehealth software provides several advantages such as timely delivery of patient information, accurate patient information, better professional satisfaction, and efficient treatment of many patients at any given time. Moreover, the adoption of cloud services across the globe has increased in recent years, thus the demand for cloud-based telehealth software services is expected to increase during the forecasted period.
By end-user, the healthcare providers segment showcased an impressive market share of 58.0% in 2021 and it is set to expand at a high CAGR of 18.5% between 2023 and 2033.
Telehealth software helps healthcare providers reduce costs, and raise productivity, and profitability in healthcare practice. It also offers convenience and quality care to patients. It provides additional functions such as data security, a multi-platform approach, registration and patient profile, mobile payment, and others. Owing to such advantages, the demand for telehealth software among healthcare providers is boosting.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Telehealth Software providers are continuously focusing on cost reduction of the product and improved service for the consumer by implementing different strategies. The companies try to improve the quality of logistics operations and responsiveness to personalize customer service and increase the efficiency of their logistics and warehousing operations.
Market Developments:
The 2023 market value is US$ 6.85 billion.
The market will flourish at a 15.7% CAGR through 2033.
Europe holds a 21.3% revenue share in the market.
Key players are Aerotel Medical System, Koninklijke Phillips NV and Teladoc Inc.
The market will reach US$ 29.56 billion in 2033.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Component
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Component, 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Component, 2023 to 2033
5.3.1. Software
5.3.1.1. Real Time Communication Software
5.3.1.2. Store and Forward
5.3.1.3. Remote Patient Monitoring
5.3.2. Services
5.3.2.1. Managed Services
5.3.2.2. Professional Services
5.4. Y-o-Y Growth Trend Analysis By Component, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Component, 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Deployment
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By Deployment, 2018 to 2022
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Deployment, 2023 to 2033
6.3.1. Cloud-based
6.3.2. On-Premises
6.4. Y-o-Y Growth Trend Analysis By Deployment, 2018 to 2022
6.5. Absolute $ Opportunity Analysis By Deployment, 2023 to 2033
7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) Analysis By End User , 2018 to 2022
7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User , 2023 to 2033
7.3.1. Healthcare providers
7.3.2. Healthcare payers and Patients
7.4. Y-o-Y Growth Trend Analysis By End User , 2018 to 2022
7.5. Absolute $ Opportunity Analysis By End User , 2023 to 2033
8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022
8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. South Asia
8.3.5. East Asia
8.3.6. Oceania
8.3.7. MEA
8.4. Market Attractiveness Analysis By Region
9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
9.2.1. By Country
9.2.1.1. The USA
9.2.1.2. Canada
9.2.2. By Component
9.2.3. By Deployment
9.2.4. By End User
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Component
9.3.3. By Deployment
9.3.4. By End User
9.4. Key Takeaways
10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Rest of Latin America
10.2.2. By Component
10.2.3. By Deployment
10.2.4. By End User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Component
10.3.3. By Deployment
10.3.4. By End User
10.4. Key Takeaways
11. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. United Kingdom
11.2.1.3. France
11.2.1.4. Spain
11.2.1.5. Italy
11.2.1.6. Rest of Europe
11.2.2. By Component
11.2.3. By Deployment
11.2.4. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Component
11.3.3. By Deployment
11.3.4. By End User
11.4. Key Takeaways
12. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. India
12.2.1.2. Malaysia
12.2.1.3. Singapore
12.2.1.4. Thailand
12.2.1.5. Rest of South Asia
12.2.2. By Component
12.2.3. By Deployment
12.2.4. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Component
12.3.3. By Deployment
12.3.4. By End User
12.4. Key Takeaways
13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. China
13.2.1.2. Japan
13.2.1.3. South Korea
13.2.2. By Component
13.2.3. By Deployment
13.2.4. By End User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Component
13.3.3. By Deployment
13.3.4. By End User
13.4. Key Takeaways
14. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
14.2.1. By Country
14.2.1.1. Australia
14.2.1.2. New Zealand
14.2.2. By Component
14.2.3. By Deployment
14.2.4. By End User
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Component
14.3.3. By Deployment
14.3.4. By End User
14.4. Key Takeaways
15. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
15.2.1. By Country
15.2.1.1. GCC Countries
15.2.1.2. South Africa
15.2.1.3. Israel
15.2.1.4. Rest of MEA
15.2.2. By Component
15.2.3. By Deployment
15.2.4. By End User
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Component
15.3.3. By Deployment
15.3.4. By End User
15.4. Key Takeaways
16. Key Countries Market Analysis
16.1. USA
16.1.1. Pricing Analysis
16.1.2. Market Share Analysis, 2022
16.1.2.1. By Component
16.1.2.2. By Deployment
16.1.2.3. By End User
16.2. Canada
16.2.1. Pricing Analysis
16.2.2. Market Share Analysis, 2022
16.2.2.1. By Component
16.2.2.2. By Deployment
16.2.2.3. By End User
16.3. Brazil
16.3.1. Pricing Analysis
16.3.2. Market Share Analysis, 2022
16.3.2.1. By Component
16.3.2.2. By Deployment
16.3.2.3. By End User
16.4. Mexico
16.4.1. Pricing Analysis
16.4.2. Market Share Analysis, 2022
16.4.2.1. By Component
16.4.2.2. By Deployment
16.4.2.3. By End User
16.5. Germany
16.5.1. Pricing Analysis
16.5.2. Market Share Analysis, 2022
16.5.2.1. By Component
16.5.2.2. By Deployment
16.5.2.3. By End User
16.6. United Kingdom
16.6.1. Pricing Analysis
16.6.2. Market Share Analysis, 2022
16.6.2.1. By Component
16.6.2.2. By Deployment
16.6.2.3. By End User
16.7. France
16.7.1. Pricing Analysis
16.7.2. Market Share Analysis, 2022
16.7.2.1. By Component
16.7.2.2. By Deployment
16.7.2.3. By End User
16.8. Spain
16.8.1. Pricing Analysis
16.8.2. Market Share Analysis, 2022
16.8.2.1. By Component
16.8.2.2. By Deployment
16.8.2.3. By End User
16.9. Italy
16.9.1. Pricing Analysis
16.9.2. Market Share Analysis, 2022
16.9.2.1. By Component
16.9.2.2. By Deployment
16.9.2.3. By End User
16.10. India
16.10.1. Pricing Analysis
16.10.2. Market Share Analysis, 2022
16.10.2.1. By Component
16.10.2.2. By Deployment
16.10.2.3. By End User
16.11. Malaysia
16.11.1. Pricing Analysis
16.11.2. Market Share Analysis, 2022
16.11.2.1. By Component
16.11.2.2. By Deployment
16.11.2.3. By End User
16.12. Singapore
16.12.1. Pricing Analysis
16.12.2. Market Share Analysis, 2022
16.12.2.1. By Component
16.12.2.2. By Deployment
16.12.2.3. By End User
16.13. Thailand
16.13.1. Pricing Analysis
16.13.2. Market Share Analysis, 2022
16.13.2.1. By Component
16.13.2.2. By Deployment
16.13.2.3. By End User
16.14. China
16.14.1. Pricing Analysis
16.14.2. Market Share Analysis, 2022
16.14.2.1. By Component
16.14.2.2. By Deployment
16.14.2.3. By End User
16.15. Japan
16.15.1. Pricing Analysis
16.15.2. Market Share Analysis, 2022
16.15.2.1. By Component
16.15.2.2. By Deployment
16.15.2.3. By End User
16.16. South Korea
16.16.1. Pricing Analysis
16.16.2. Market Share Analysis, 2022
16.16.2.1. By Component
16.16.2.2. By Deployment
16.16.2.3. By End User
16.17. Australia
16.17.1. Pricing Analysis
16.17.2. Market Share Analysis, 2022
16.17.2.1. By Component
16.17.2.2. By Deployment
16.17.2.3. By End User
16.18. New Zealand
16.18.1. Pricing Analysis
16.18.2. Market Share Analysis, 2022
16.18.2.1. By Component
16.18.2.2. By Deployment
16.18.2.3. By End User
16.19. GCC Countries
16.19.1. Pricing Analysis
16.19.2. Market Share Analysis, 2022
16.19.2.1. By Component
16.19.2.2. By Deployment
16.19.2.3. By End User
16.20. South Africa
16.20.1. Pricing Analysis
16.20.2. Market Share Analysis, 2022
16.20.2.1. By Component
16.20.2.2. By Deployment
16.20.2.3. By End User
16.21. Israel
16.21.1. Pricing Analysis
16.21.2. Market Share Analysis, 2022
16.21.2.1. By Component
16.21.2.2. By Deployment
16.21.2.3. By End User
17. Market Structure Analysis
17.1. Competition Dashboard
17.2. Competition Benchmarking
17.3. Market Share Analysis of Top Players
17.3.1. By Regional
17.3.2. By Component
17.3.3. By Deployment
17.3.4. By End User
18. Competition Analysis
18.1. Competition Deep Dive
18.1.1. Aerotel Medical System
18.1.1.1. Overview
18.1.1.2. Product Portfolio
18.1.1.3. Profitability by Market Segments
18.1.1.4. Sales Footprint
18.1.1.5. Strategy Overview
18.1.1.5.1. Marketing Strategy
18.1.2. Koninklijke phillips NV
18.1.2.1. Overview
18.1.2.2. Product Portfolio
18.1.2.3. Profitability by Market Segments
18.1.2.4. Sales Footprint
18.1.2.5. Strategy Overview
18.1.2.5.1. Marketing Strategy
18.1.3. Teladoc Inc.
18.1.3.1. Overview
18.1.3.2. Product Portfolio
18.1.3.3. Profitability by Market Segments
18.1.3.4. Sales Footprint
18.1.3.5. Strategy Overview
18.1.3.5.1. Marketing Strategy
18.1.4. American Well
18.1.4.1. Overview
18.1.4.2. Product Portfolio
18.1.4.3. Profitability by Market Segments
18.1.4.4. Sales Footprint
18.1.4.5. Strategy Overview
18.1.4.5.1. Marketing Strategy
18.1.5. Chiron health
18.1.5.1. Overview
18.1.5.2. Product Portfolio
18.1.5.3. Profitability by Market Segments
18.1.5.4. Sales Footprint
18.1.5.5. Strategy Overview
18.1.5.5.1. Marketing Strategy
18.1.6. Medtronic
18.1.6.1. Overview
18.1.6.2. Product Portfolio
18.1.6.3. Profitability by Market Segments
18.1.6.4. Sales Footprint
18.1.6.5. Strategy Overview
18.1.6.5.1. Marketing Strategy
18.1.7. Honeywell International
18.1.7.1. Overview
18.1.7.2. Product Portfolio
18.1.7.3. Profitability by Market Segments
18.1.7.4. Sales Footprint
18.1.7.5. Strategy Overview
18.1.7.5.1. Marketing Strategy
18.1.8. Tunstall healthcare
18.1.8.1. Overview
18.1.8.2. Product Portfolio
18.1.8.3. Profitability by Market Segments
18.1.8.4. Sales Footprint
18.1.8.5. Strategy Overview
18.1.8.5.1. Marketing Strategy
18.1.9. AMD Global Telemedicine
18.1.9.1. Overview
18.1.9.2. Product Portfolio
18.1.9.3. Profitability by Market Segments
18.1.9.4. Sales Footprint
18.1.9.5. Strategy Overview
18.1.9.5.1. Marketing Strategy
18.1.10. Cisco System
18.1.10.1. Overview
18.1.10.2. Product Portfolio
18.1.10.3. Profitability by Market Segments
18.1.10.4. Sales Footprint
18.1.10.5. Strategy Overview
18.1.10.5.1. Marketing Strategy
18.1.11. Medvivo group
18.1.11.1. Overview
18.1.11.2. Product Portfolio
18.1.11.3. Profitability by Market Segments
18.1.11.4. Sales Footprint
18.1.11.5. Strategy Overview
18.1.11.5.1. Marketing Strategy
18.1.12. Global Media Group
18.1.12.1. Overview
18.1.12.2. Product Portfolio
18.1.12.3. Profitability by Market Segments
18.1.12.4. Sales Footprint
18.1.12.5. Strategy Overview
18.1.12.5.1. Marketing Strategy
18.1.13. Cerner Corporation
18.1.13.1. Overview
18.1.13.2. Product Portfolio
18.1.13.3. Profitability by Market Segments
18.1.13.4. Sales Footprint
18.1.13.5. Strategy Overview
18.1.13.5.1. Marketing Strategy
18.1.14. Care Innovation
18.1.14.1. Overview
18.1.14.2. Product Portfolio
18.1.14.3. Profitability by Market Segments
18.1.14.4. Sales Footprint
18.1.14.5. Strategy Overview
18.1.14.5.1. Marketing Strategy
19. Assumptions & Acronyms Used
20. Research Methodology
Explore Technology Insights
View Reports
Telehealth Software Market
